id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-276524-th6eu11h	Atallah, Bassam	Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers	2020-09-09		.txt	text/plain	2630	141	42	His D-dimer was over 6 times the upper limit of normal (ULN) and started on intensified prophylaxis with unfractionated heparin infusion (UFH) 7500 units TID per our COVID anticoagulation protocol [4] . D-dimer was over 6 times ULN on transfer: Patient was directly placed on high intensity thromboprophylaxis with heparin 7500 SC TID and received tocilizumab on second day of admission. Additionally, the fact that thrombotic events continued to be observed despite decrease in inflammatory markers and the proactive anticoagulative approach adopted, raises more questions about the coagulative mechanisms at play in COVID-19, and the appropriate management strategy. Additionally, the fact that thrombotic events continued to be observed despite decrease in inflammatory markers and the proactive anticoagulative approach adopted, raises more questions about the coagulative mechanisms at play in COVID-19, and the appropriate management strategy.	./cache/cord-276524-th6eu11h.txt	./txt/cord-276524-th6eu11h.txt